1. Home
  2. PRPL vs GANX Comparison

PRPL vs GANX Comparison

Compare PRPL & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.64

Market Cap

76.9M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

78.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
GANX
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
78.2M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
PRPL
GANX
Price
$0.64
$2.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$0.85
$7.50
AVG Volume (30 Days)
283.1K
684.8K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
152.75
31.46
EPS
0.48
N/A
Revenue
$468,725,000.00
$55,180.00
Revenue This Year
$10.83
N/A
Revenue Next Year
$6.81
N/A
P/E Ratio
$1.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$1.41
52 Week High
$1.26
$4.34

Technical Indicators

Market Signals
Indicator
PRPL
GANX
Relative Strength Index (RSI) 45.72 52.11
Support Level $0.57 $1.55
Resistance Level $0.73 $2.40
Average True Range (ATR) 0.04 0.14
MACD -0.00 0.04
Stochastic Oscillator 24.24 82.56

Price Performance

Historical Comparison
PRPL
GANX

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: